Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ABT - ABBOTT LABORATORIES


133.17
0.210   0.158%

Share volume: 5,043,397
Last Updated: Thu 20 Feb 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing : -0.22%

PREVIOUS CLOSE
CHG
CHG%

$132.96
1.04
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 47%
Dept financing 24%
Liquidity 20%
Performance 56%
Company vs Stock growth
vs
Performance
5 Days
2.30%
1 Month
14.03%
3 Months
13.57%
6 Months
19.55%
1 Year
12.98%
2 Year
28.48%
Key data
Stock price
$133.17
P/E Ratio 
34.24
DAY RANGE
$131.35 - $133.28
EPS 
$3.30
52 WEEK RANGE
$99.71 - $133.28
52 WEEK CHANGE
$11.48
MARKET CAP 
197.435 B
YIELD 
1.90%
SHARES OUTSTANDING 
1.740 B
DIVIDEND
$0.55
EX-DIVIDEND DATE
07/15/2024
NEXT EARNINGS DATE
N/A
BETA 
0.24
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,555,270
AVERAGE 30 VOLUME 
$7,276,102
Company detail
CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: 1983
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

Recent news